An implementation-efficacy trial of a collaborative prescriber-pharmacist model for Medication Assisted Treatment for Opioid Dependence

Background: A lack of prescribers in the community limits access to Medication Assisted Treatment for Opioid Dependence (MATOD). The Enhancing Pharmacists Involvement in Care (EPIC)-MATOD study will evaluate clinical and implementation outcomes of a collaborative pharmacist-prescriber model of care

Methods: Patients receiving collaborative care, a comparison cohort, pharmacists, and prescribers are being recruited in Victoria, Australia, and will be followed up over 6 (patients) and 12 months (pharmacists/prescribers) in a hybrid implementation-efficacy study. The primary clinical endpoint is patient retention at 26 weeks. The primary implementation outcome is treatment capacity. Time and costs will be estimated

Results: Nine pharmacists, 3 prescribers, and 13 patients have entered the study, with recruitment ongoing
Conclusions: The study will provide information on outcomes, acceptability, and cost of collaborative care for MATOD

Presenter

Ali Cheetham, Research Officer, Monash Addiction Research Centre

Ali Cheetham is a research officer at the Monash Addiction Research Centre and Turning Point. Since completing her Ph.D. in 2013 her role has included involvement in projects that identify barriers and facilitators to seeking help for AOD and mental health problems, and encouraging engagement with services and treatment. She has been the project officer for the EPIC-MATOD project since 2020.

 

Credited Authors

Suzanne Neilsen, Professor, Monash Addiction Research Centre

Kirsty Morgan, AOD Educator, Peninsula Health